SCHEMBL22330574

SCHEMBL22330574

CC(=O)Cc1cc(-c2ncccc2CO)ccc1OCC(C)C

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HIF1A Q16665 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
PTGER1 P34995 5/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
AAK1 Q2M2I8 1/20 0.37
XDH P47989 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
FOS P01100 1/20 0.35
JUN P05412 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22330510 0.85 DHODH (0.43) DHODHALDH1A1HIF1ATRPV1PTGER1
SCHEMBL18562815 0.74 HPGD (0.51) ALDH1A1MAPT
SCHEMBL26725046 0.74 L3MBTL1 (0.64) ALDH1A1HIF1AL3MBTL1MAPTPKM
SCHEMBL22916183 0.73 ALDH1A1 (0.55) ALDH1A1HIF1APTGER1L3MBTL1MAPT
SCHEMBL17039801 0.73 LMNA (0.52) ALDH1A1MEN1KMT2AMAPT
SCHEMBL17039776 0.72 LMNA (0.50) ALDH1A1L3MBTL1TSHRHTT
SCHEMBL18562793 0.71 MAPK1 (0.44) ALDH1A1HTT
SCHEMBL11620358 0.71 KDM4E (0.55) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL2355180 0.68 ADRB2 (0.44) MEN1KMT2ATSHR
SCHEMBL3583816 0.67 XDH (0.66) XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107899-B1 MITOCHONDRIAL ALDEHYDE DEHYDROGENASE 2 (ALDH2) BINDING POLYCYCLIC AMIDES AND THEIR USE FOR THE TREATMENT OF CANCER AVIV THERAPEUTICS INC (US) 2020-08-12 EP disclosed